ZX008 Receives FDA Orphan Drug Status for Treatment of Lennox Gastaut Syndrome
News
Zogenix’s ZX008 (low-dose fenfluramine) has been granted Orphan Drug designation by the Food and Drug Administration (FDA) as a potential treatment for Lennox Gastaut Syndrome (LGS), a severe childhood form of ... Read more